A phase III trial to compare the efficacy, safety,...

Annals of Oncology 2020 / 09 Vol. 31

A phase III trial to compare the efficacy, safety, pharmacokinetics and immunogenicity of HD201 to trastuzumab in HER2+ early breast cancer patients (TROIKA)

Xavier, P., Hii, C.S.J., Mclendon, K., Feyaerts, P., Felicia, A., J. litha,, Demarchi, M.F., Coliat, P., Deforce, F., Derde, M.P., Kim, M.J., Park, L.S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.288
Date:
September, 2020
File:
PDF, 73 KB
2020
Conversion to is in progress
Conversion to is failed